Next |
home / stock / slgl / slgl message board
Subject | By | Source | When |
---|---|---|---|
By the market reaction, not | midastouch017 | investorshub | 07/27/2021 1:57:44 PM |
Finally the approval The target patient population is big | Amatuer17 | investorshub | 07/27/2021 1:36:58 PM |
Sol-Gel Technologies Provides Update on FDA Review of EPSOLAY | midastouch017 | investorshub | 04/27/2021 2:25:29 PM |
PDUFA Dates | midastouch017 | investorshub | 04/25/2021 6:47:19 AM |
Wow, a year ago today SLGL | midastouch017 | investorshub | 03/12/2021 5:13:52 PM |
I thought we discussed$ BVXV at the time, | midastouch017 | investorshub | 10/13/2020 9:00:11 PM |
$BVXV - did not know about that stock | Amatuer17 | investorshub | 10/13/2020 7:58:25 PM |
So is $BVXV! | midastouch017 | investorshub | 10/13/2020 5:54:11 PM |
I looked at it and missed it. Doing | Amatuer17 | investorshub | 10/13/2020 5:42:49 PM |
One other Israeli stock worth looking into | midastouch017 | investorshub | 07/11/2020 1:38:09 PM |
This one has potential - good news is | midastouch017 | investorshub | 07/11/2020 1:17:35 PM |
Sol-Gel Technologies Reports First Quarter 2020 Financial Results | midastouch017 | investorshub | 05/14/2020 11:33:43 AM |
Sol-Gel Technologies to Report First Quarter 2020 Financial | midastouch017 | investorshub | 05/08/2020 12:41:49 PM |
Thanks for highlighting those 2 important points my friend!!! | DorseyE | investorshub | 04/28/2020 12:29:28 AM |
Aquestive Therapeutics Inc. ($AQST) | midastouch017 | investorshub | 04/26/2020 1:15:39 PM |
Thanks, they are killing me! | DorseyE | investorshub | 04/26/2020 12:04:13 AM |
POP UP ADDS | midastouch017 | investorshub | 04/20/2020 6:26:59 PM |
Man I hate these POP UP ADDS just | DorseyE | investorshub | 04/20/2020 5:50:56 PM |
3 Top Biotech Stocks with FDA Approvals on | midastouch017 | investorshub | 04/20/2020 9:54:12 AM |
Since i am staying at home, i have | midastouch017 | investorshub | 04/19/2020 7:53:51 AM |
News, Short Squeeze, Breakout and More Instantly...
Sol-Gel Technologies Ltd. Company Name:
SLGL Stock Symbol:
NASDAQ Market:
NESS ZIONA, Israel, April 01, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company pioneering treatments for patients with severe skin conditions, conducting a Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome, and with two approved lar...
An ongoing phase 3 clinical trial of SGT-610 for Gorlin Syndrome with the first patient screened; Results are expected by the end of 2025 Sol-Gel maintains a cash runway into the second half of 2025 NESS ZIONA, Israel, March 13, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. ...
Genesco Inc. (GCO) is expected to report $2.66 for Q4 2024 Broadway Financial Corporation (BYFC) is expected to report for quarter end 2023-12-31 Oji Holdings Corporation ADR (OJIPY) is expected to report for Q3 2024 Hibbett Inc. (HIBB) is expected to report $2.54 for Q4 2024 GRI ...